RJA
AMGN icon

Robshaw & Julian Associates’s Amgen AMGN Stock Holding History

Robshaw & Julian Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$6.01M Buy
34,685
+525
+2% +$85.4K 4.31% 6
2017
Q1 		$5.61M Sell
34,160
-5
-0% -$831 4.05% 7
2016
Q4 		$5M Buy
34,165
+870
+3% +$131K 3.69% 10
2016
Q3 		$5.55M Hold
33,295
– – 4.13% 3
2016
Q2 		$5.07M Buy
33,295
+4,090
+14% +$636K 3.87% 4
2016
Q1 		$4.38M Buy
29,205
+25
+0.1% +$3.71K 3.3% 13
2015
Q4 		$4.74M Buy
29,180
+695
+2% +$109K 3.67% 10
2015
Q3 		$3.94M Sell
28,485
-35
-0.1% -$5.52K 3.33% 14
2015
Q2 		$4.38M Sell
28,520
-2,450
-8% -$392K 3.36% 15
2015
Q1 		$4.83M Sell
30,970
-4,375
-12% -$689K 3.63% 13
2014
Q4 		$5.63M Sell
35,345
-525
-1% -$81.8K 4.42% 5
2014
Q3 		$5.04M Buy
35,870
+875
+3% +$114K 3.97% 6
2014
Q2 		$4.14M Sell
34,995
-900
-3% -$104K 3.18% 17
2014
Q1 		$4.43M Buy
35,895
+625
+2% +$75.8K 3.41% 11
2013
Q4 		$4.02M Buy
35,270
+625
+2% +$71.1K 3.33% 12
2013
Q3 		$3.88M Sell
34,645
-150
-0.4% -$16.3K 3.3% 10
2013
Q2 		$3.43M Buy
+34,795
New +$3.61M 3.23% 13

Other funds holding AMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Robshaw & Julian Associates's AMGN Position: Q2 2017 in Review

Robshaw & Julian Associates increased its Amgen (AMGN) stake by 1.5% in Q2 2017, buying an estimated $85.4K and bringing the position to 34,685 shares worth $6.01M. The position accounts for 4.31% of the portfolio, ranked #6.

Robshaw & Julian Associates first reported a position in AMGN in Q2 2013 and has held it in 17 quarters since. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Robshaw & Julian Associates held 34,685 shares of Amgen worth $6.01M as of Q2 2017.
  • Robshaw & Julian Associates bought 525 Amgen shares in Q2 2017, an estimated $85.4K.
  • Amgen made up 4.31% of Robshaw & Julian Associates's portfolio in Q2 2017, its #6 holding.
  • Robshaw & Julian Associates first reported a position in Amgen in Q2 2013 and has held it in 17 quarters since.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Robshaw & Julian Associates's 13F filing for Q2 2017, filed 3 Aug 2017.